VALIDATION METHODS FOR QUANTITATIVE DETERMINATION OF 4,4'-DIMETHYL-7,7'-ETHYLENDIOXY-2H-1-DIBENZOPYRAN-2,2'-DIONE SUBSTANCE

Introduction. One of the most promising synthetic compounds of coumarin derivatives is immunacor-4,4'-dimethyl-7,7'-ethylenedioxy-2H-1-dibenzopyran-2,2'-dione. As a result of preclinical studies, it has been shown that it is promising in medical practice as an immunomodulator for the...

Full description

Saved in:
Bibliographic Details
Main Authors: C. B. Nguyen, A. Z. Abyshev
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-02-01
Series:Разработка и регистрация лекарственных средств
Subjects:
Online Access:https://www.pharmjournal.ru/jour/article/view/648
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849696272769875968
author C. B. Nguyen
A. Z. Abyshev
author_facet C. B. Nguyen
A. Z. Abyshev
author_sort C. B. Nguyen
collection DOAJ
description Introduction. One of the most promising synthetic compounds of coumarin derivatives is immunacor-4,4'-dimethyl-7,7'-ethylenedioxy-2H-1-dibenzopyran-2,2'-dione. As a result of preclinical studies, it has been shown that it is promising in medical practice as an immunomodulator for the treatment and prevention of secondary immunodeficiency diseases.Aim. The objective of this work is to develop methods for HPLC and UV spectrophotometry to determine the quantitative determination of the immunacor substance and to study the complex of validation characteristics of the developed methods.Materials and methods. Quantitative analysis of the substance was carried out by UV-Spectrophotometry and HPLC. Validation procedures were performed on parameters: specificity, linearity, accuracy and precision in accordance with the requirements of FP XIV. Results and discussion. Validation characteristics have been determined, and their compliance with the relevant eligibility criteria has been experimentally verified.Conclusion. Methods for quantitative determination of the active component in 4,4'-dimethyl-7,7'-ethylenedioxy-2H-1-dibenzopyran-2,2'-dione (immunacor) pharmaceutical substance by HPLC and UV spectrophotometry has been developed. It is established that methods are specific, accurate, precise and linear in the analytical field. The precision HPLC method far exceeds the UV-spectrophotometry.
format Article
id doaj-art-efe0101a9dbe4ef1bbb7532fa31d52c0
institution DOAJ
issn 2305-2066
2658-5049
language Russian
publishDate 2019-02-01
publisher LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
record_format Article
series Разработка и регистрация лекарственных средств
spelling doaj-art-efe0101a9dbe4ef1bbb7532fa31d52c02025-08-20T03:19:31ZrusLLC Center of Pharmaceutical Analytics (LLC «CPHA»)Разработка и регистрация лекарственных средств2305-20662658-50492019-02-0181596510.33380/2305-2066-2019-8-1-59-65648VALIDATION METHODS FOR QUANTITATIVE DETERMINATION OF 4,4'-DIMETHYL-7,7'-ETHYLENDIOXY-2H-1-DIBENZOPYRAN-2,2'-DIONE SUBSTANCEC. B. Nguyen0A. Z. Abyshev1Saint-Petersburg State Chemical and Pharmaceutical UniversitySaint-Petersburg State Chemical and Pharmaceutical UniversityIntroduction. One of the most promising synthetic compounds of coumarin derivatives is immunacor-4,4'-dimethyl-7,7'-ethylenedioxy-2H-1-dibenzopyran-2,2'-dione. As a result of preclinical studies, it has been shown that it is promising in medical practice as an immunomodulator for the treatment and prevention of secondary immunodeficiency diseases.Aim. The objective of this work is to develop methods for HPLC and UV spectrophotometry to determine the quantitative determination of the immunacor substance and to study the complex of validation characteristics of the developed methods.Materials and methods. Quantitative analysis of the substance was carried out by UV-Spectrophotometry and HPLC. Validation procedures were performed on parameters: specificity, linearity, accuracy and precision in accordance with the requirements of FP XIV. Results and discussion. Validation characteristics have been determined, and their compliance with the relevant eligibility criteria has been experimentally verified.Conclusion. Methods for quantitative determination of the active component in 4,4'-dimethyl-7,7'-ethylenedioxy-2H-1-dibenzopyran-2,2'-dione (immunacor) pharmaceutical substance by HPLC and UV spectrophotometry has been developed. It is established that methods are specific, accurate, precise and linear in the analytical field. The precision HPLC method far exceeds the UV-spectrophotometry.https://www.pharmjournal.ru/jour/article/view/648immunacorcoumarinshplcuv-spectrophotometryquantitative determinationvalidation
spellingShingle C. B. Nguyen
A. Z. Abyshev
VALIDATION METHODS FOR QUANTITATIVE DETERMINATION OF 4,4'-DIMETHYL-7,7'-ETHYLENDIOXY-2H-1-DIBENZOPYRAN-2,2'-DIONE SUBSTANCE
Разработка и регистрация лекарственных средств
immunacor
coumarins
hplc
uv-spectrophotometry
quantitative determination
validation
title VALIDATION METHODS FOR QUANTITATIVE DETERMINATION OF 4,4'-DIMETHYL-7,7'-ETHYLENDIOXY-2H-1-DIBENZOPYRAN-2,2'-DIONE SUBSTANCE
title_full VALIDATION METHODS FOR QUANTITATIVE DETERMINATION OF 4,4'-DIMETHYL-7,7'-ETHYLENDIOXY-2H-1-DIBENZOPYRAN-2,2'-DIONE SUBSTANCE
title_fullStr VALIDATION METHODS FOR QUANTITATIVE DETERMINATION OF 4,4'-DIMETHYL-7,7'-ETHYLENDIOXY-2H-1-DIBENZOPYRAN-2,2'-DIONE SUBSTANCE
title_full_unstemmed VALIDATION METHODS FOR QUANTITATIVE DETERMINATION OF 4,4'-DIMETHYL-7,7'-ETHYLENDIOXY-2H-1-DIBENZOPYRAN-2,2'-DIONE SUBSTANCE
title_short VALIDATION METHODS FOR QUANTITATIVE DETERMINATION OF 4,4'-DIMETHYL-7,7'-ETHYLENDIOXY-2H-1-DIBENZOPYRAN-2,2'-DIONE SUBSTANCE
title_sort validation methods for quantitative determination of 4 4 dimethyl 7 7 ethylendioxy 2h 1 dibenzopyran 2 2 dione substance
topic immunacor
coumarins
hplc
uv-spectrophotometry
quantitative determination
validation
url https://www.pharmjournal.ru/jour/article/view/648
work_keys_str_mv AT cbnguyen validationmethodsforquantitativedeterminationof44dimethyl77ethylendioxy2h1dibenzopyran22dionesubstance
AT azabyshev validationmethodsforquantitativedeterminationof44dimethyl77ethylendioxy2h1dibenzopyran22dionesubstance